Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value.The ex-Pfizer executives, Ian Read and Frank D'Amelio,
Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
Starboard’s Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as “flagrantly unethical.”
Activist investor claims Pfizer coerced former execs amid power struggle
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard Value.
Activist Investor Starboard Value Presses Pfizer's Board Amid Corporate Tensions
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard pushed Pfizers board to investigate alleged coercive actions. This follows the
Will Pfizer transform in response to Starboard’s activism?
Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the potential impact on the company. Read more here.
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer’s Ex-CEO Won’t Be Involved in Starboard Value Effort
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to a statement released on their behalf late Wednesday.
Pfizer’s stock dips after two former execs say they won’t support Starboard
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO Albert Bourla.
Former Pfizer executives pull out of activist investor Starboard’s campaign
Former chief executive and chair Ian Read and former finance chief Frank D’Amelio have decided not to be involved in Starboard’s campaign targeting the drugmaker, they said in a statement on Wednesday.
Pfizer battles activist fund Starboard, which has a $1 billion stake in company
CNBC Angelica Peebles joins 'Power Lunch' to report on Pfizer's activist battle. Scenes from Florida in the aftermath of Hurricane Milton Dementia cases are on the rise — avoid these 12 risks to keep
pharmaphorum4h
Starboard claims Pfizer 'threatened' former leaders
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Former Pfizer CEO, CFO Say They Will Not Be Involved in Starboard's Campaign Against Drugmaker
(Reuters) -Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor ...
Former Pfizer Executives Ian Read And Frank D'Amelio Support Albert Bourla's Leadership Amid Starboard Activism: 'Will Deliver Shareholder Value'
CEO Ian Read and ex-CFO Frank D’Amelio have decided to distance themselves from the activist campaign led by Starboard Value ...
Former Pfizer Executives Ian Read And Frank D'Amelio Decline Involvement With Starboard's Efforts
Guggenheim Securities, LLC has issued a statement on behalf of former Pfizer Chief Executive Officer Ian Read and former Chief ...
What's Going On With Pfizer Stock On Thursday?
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...